Evidence map›Paper›PMID 39002086›Full record

ArticleBiotechnology letters2024

From yeast screening for suitability as single cell protein to fed-batch cultures.

Alexander Anderson, Adriaan Van der Mijnsbrugge, Xavier Cameleyre, Nathalie Gorret

Abstract read
PubMed Publisher
In one paragraph

Article in Biotechnology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Screening of wild-typeFood science and biotechnology · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexander AndersonTBI, Université de Toulouse, CNRS, INRAE, INSA, Toulouse, France.
Adriaan Van der MijnsbruggeTereos, Burchtstraat 10, 9300, Aalst, Belgium.
Xavier Cameleyre *TBI, Université de Toulouse, CNRS, INRAE, INSA, Toulouse, France.
Nathalie Gorret *TBI, Université de Toulouse, CNRS, INRAE, INSA, Toulouse, France. ngorret@insa-toulouse.fr.ORCID http://orcid.org/0000-0002-5290-1316

Funding

Agence Nationale de la Recherche ANR-18-EURE-0021
6 · The paper itself

Abstract

purposeFed-batch cultures have rarely been used in single cell protein (SCP) research. This work evaluated multiple yeast species for suitability as SCP cultivated using glucose- and sucrose-based substrate and performed in-depth studies of fed-batch SCP cultivation kinetics for selected yeasts, including determination of specific crude nitrogen-to-protein conversion factors.

methodsSCP was cultivated using fully synthetic media in flask batch or bioreactor fed-batch cultures. Crude nitrogen and nucleic acid content were determined using the Dumas method and fluorescence assay kits, respectively.

resultsC. utilis compared favorably to other yeasts in flask batch cultures in terms of process yield (0.52 ± 0.01 g

conclusionThis study demonstrated the suitability of C. utilis as SCP, notably the robustness of its crude nitrogen content (as an indicator of protein content) across batch and fed-batch conditions, compared to that of the benchmark yeast S. cerevisiae.

Indexed as

Batch Cell Culture TechniquesBioreactorsNitrogenBiomassCulture MediaDietary ProteinsGlucoseSaccharomyces cerevisiaeSucroseYeastsCulture MediaDietary ProteinsGlucoseNitrogensingle cell proteinsSucroseFed batchKinetic analysisNucleic acidSCPScreeningYeast

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.